ARKGvsPSCHETF Comparison
VS
ARK Genomic Revolution ETF (ARKG) belongs to the BioTech & Genomics segment. Invesco S&P SmallCap Health Care ETF (PSCH) is part of the US Health Care segment. Both ETFs have the same top 1 sector exposures: Healthcare. ARKG is more expensive with a Total Expense Ratio (TER) of 0.75%, versus 0.29% for PSCH. ARKG is up 76.72% year-to-date (YTD) with +$90M in YTD flows. PSCH performs worse with 24.19% YTD performance, and -$1M in YTD flows. Run a side-by-side ETF comparison of ARKG and PSCH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
ARKG vs PSCH performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/27/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | ARKG PSCH | -3.25%+2.63% | +36.71%+3.48% | +76.72%+24.19% | +65.56%+27.93% | +132.21%+57.69% | -29.90%-7.08% |
| Flows | ARKG PSCH | +$37M-$11M | +$51M+$9M | +$90M-$1M | +$63M-$921K | -$431M-$102M | -$2.01B-$210M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | ARKG PSCH | +49.99%+16.95% | +44.59%+19.44% | +44.73%+21.78% | +46.89%+22.92% |
| Max drawdown | ARKG PSCH | -17.81%-8.61% | -27.52%-15.36% | -46.41%-22.80% | -76.56%-45.76% |
| Max drawdown duration | ARKG PSCH | 22d69d | 126d168d | 882d488d | 1818d1814d |
Trading data
ARKG | PSCH | |
Last sale 10/28/2026 at 1:30 PM | $54.82 | $55.06 |
| Previous close 10/27/2026 | $51.65 | $54.75 |
| Consolidated volume 10/27/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
ARKG
is actively managed and doesn’t replicate an indexARKG | PSCH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/28/2026 at 1:30 PM
Live
Closed
ARKG | PSCH | |
|---|---|---|
| Last price | $54.82 | $55.06 |
| 1D performance | +6.14% | +0.57% |
| AuM | $2.18 B | $176.30 M |
| E/R | 0.75% | 0.29% |
Characteristics
ARKG | PSCH | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Ark Investment | Invesco |
| Benchmark | - | S&P SmallCap 600 Capped Health Care Index |
| N° of holdings | 31 | 69 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 2, 2019 | April 7, 2010 |
| ESG | No | No |
Advertisement
Exposure
Countries
ARKG
USA
88.62%
Other
11.38%
PSCH
USA
94.93%
Other
5.07%
Sectors
ARKG
Healthcare
97.89%
Other
2.11%
PSCH
Healthcare
100%
Other
0%
Advertisement
Diversification
ARKG
Total weight of top 15 holdings out of 15
74.64%
PSCH
Total weight of top 15 holdings out of 15
48.62%
Top 15 holdings
Data as of August 31, 2026
ARKG
10X Genomics, Inc.
9.58%
Twist Bioscience Corp.
9.13%
Tempus AI, Inc.
7.91%
CRISPR Therapeutics AG
6.10%
Personalis, Inc.
5.93%
Absci Corp.
4.88%
Natera, Inc.
4.06%
Illumina, Inc.
4.04%
Eli Lilly & Co.
3.86%
CareDx, Inc.
3.85%
Guardant Health, Inc.
3.81%
Beam Therapeutics, Inc.
3.56%
Compass Pathways Plc
3.17%
Recursion Pharmaceuticals, Inc.
2.44%
Adaptive Biotechnologies Corp.
2.32%
PSCH
Corcept Therapeutics, Inc.
5.61%
Glaukos Corp.
5.37%
Protagonist Therapeutics, Inc.
4.54%
Alkermes Plc
4.09%
TG Therapeutics, Inc.
3.69%
Teleflex, Inc.
3.06%
PTC Therapeutics, Inc.
2.99%
Ligand Pharmaceuticals, Inc.
2.87%
Merit Medical Systems, Inc.
2.68%
RadNet, Inc.
2.68%
Liquidia Corp.
2.47%
ICU Medical, Inc.
2.20%
Indivior Pharmaceuticals, Inc.
2.16%
Integer Holdings Corp.
2.14%
Concentra Group Holdings Parent, Inc.
2.07%
Frequently asked questions about ARKG and PSCH
How have the ARKG and PSCH ETFs performed in 2026?
As of October 27, 2026, ARKG is up 76.72% year-to-date (YTD), while PSCH has returned 24.19%. That puts ARKG better performer ahead so far this year.
Which ETF is attracting more investor money: ARKG or PSCH?
Year-to-date, the ARKG ETF saw +$90M in flows, compared to -$1M for PSCH.
Which ETF is more volatile: ARKG or PSCH?
Over the past year, ARKG had a volatility of 44.59%, while PSCH experienced 19.44%.
Which ETF is bigger: ARKG or PSCH?
As of October 27, 2026, ARKG holds $2.18 B in assets under management (AUM), while PSCH manages $176.30 M.
What sectors do the ARKG and PSCH ETFs invest in?
ARKG leans toward sectors like Healthcare. Meanwhile, PSCH focuses on Healthcare.
What are the top holdings of the ARKG ETF and PSCH ETF?
ARKG top holdings include 10X Genomics, Inc., Twist Bioscience Corp. and Tempus AI, Inc.. PSCH holds in its top three: Corcept Therapeutics, Inc., Glaukos Corp. and Protagonist Therapeutics, Inc..
Which ETF is more diversified: ARKG or PSCH?
ARKG holds 31 securities with 74.64% of its assets in the top 15. PSCH has 69 securities and a top 15 weight of 48.62%.
Advertisement
Latest news about ARKG & PSCH
The Weekly ETF Market Monitor (October 19-23, 2026)
October 26, 2026
ARKG
Biotech ETFs – Investing in Health Innovation
July 21, 2022
ARKG
Advertisement
Advertisement
